News
US FDA approves Precigen’s Papzimeos for the treatment of adults with recurrent respiratory papillomatosis: Germantown, Maryland Monday, August 18, 2025, 17:00 Hrs [IST] Precige ...
Precigen’s immunotherapy will likely reduce the need for repeat surgeries in recurrent respiratory papillomatosis (RRP) ...
Researchers from Children's Hospital of Philadelphia (CHOP) and Children's Hospital Colorado have found that better control ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback